Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 16, No 1 (2020) The Efficacy, Safety and Adherence to Treatment when New Anticoagulants Taking in Over 75 Years Old Patients with Atrial Fibrillation Abstract  similar documents
A. N. Turov, S. V. Panfilov, О. V. Tschiglinzeva
"... of myocardial infarction was 0.8% per year, surgical revascularization – 0.9% per year, cardiovascular death – 0 ..."
 
Vol 10, No 6 (2014) THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER Abstract  similar documents
S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina
"... Aim. To study in the PROFILE register the rate of new oral anticoagulants (NOAC) taking ..."
 
Vol 11, No 5 (2015) Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism Abstract  similar documents
A. V. Rudakova
"... horizon of the study was 5 years. Life expectancy and costs were discounted by 3.5% per year. The costs ..."
 
Vol 15, No 6 (2019) Adherence to Treatment with New Oral Anticoagulants in Atrial Fibrillation Patients in Real Clinical Practice (Results of the ANTEY Study) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, S. N. Tolpygina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, N. A. Komkova
"... Aim. To study adherence to treatment with new oral anticoagulants (NOAC) and factors associated ..."
 
Vol 13, No 5 (2017) DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov
"...   favorable profile of drug  interaction in comparison with other new oral anticoagulants (NOAC). The basis ..."
 
Vol 14, No 4 (2018) Risk Controlling of Gastrointestinal Bleeding in Comorbid Patients with Cardiovascular Diseases Abstract  similar documents
O. Yu. Chizhova, L. N. Belousova, I. G. Bakulin
"... anticoagulants (NOACs), previously known as new oral anticoagulants are used in the treatment and prevention ..."
 
Vol 14, No 2 (2018) WHAT DO PATIENTS WITH ATRIAL FIBRILLATION KNOW ABOUT STROKE AND SYSTEMIC EMBOLISM PREVENTION? DATA OF THE PRIMA-TERRA REGISTRY Abstract  similar documents
R. М. Linchak, O. G. Kompaniyets, A. M. Nedbaykin
"... . The ratio of men and women was 42% vs 58%, respectively, the average age was 65.6Ѓ}8.2 years. The AF ..."
 
Vol 12, No 4 (2016) The use of oral anticoagulants in patients with atrial fibrillation: cohort study data Abstract  similar documents
O. V. Gaisenok, A. S. Leonov
"... OAC (NOAC), prescription depending type AF and the reasons for their not-prescribing were studied ..."
 
Vol 16, No 1 (2020) Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice Abstract  similar documents
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko
"... of 62.55±11.12 years. Exclusion criteria were mitral stenosis, mechanic prosthetic valve, first episode ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... . In connection with the known disadvantages of warfarin use, the elaboration of new oral anticoagulants (NOAC ..."
 
Vol 12, No 1 (2016) Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis Abstract  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov
"... Aim. Analysis of the efficacy and safety of the new oral anticoagulants (NOACs) in the management ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... . Material and methods. Treatment adherence was evaluated in 137 AF patients (aged 35-85 years ..."
 
Vol 14, No 4 (2018) Hepatotoxicity of New Oral Anticoagulants Abstract  similar documents
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
"... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..."
 
Vol 12, No 3 (2016) THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT Abstract  PDF (Eng)  similar documents
S. R. Gilyarevskiy
"... , as well as the choice of anticoagulants, including new oral anticoagulants (NOAC). EINSTEIN-PE is the only ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... lately new oral anticoagulants (NOAC) are becoming more common for the prevention of thromboembolic ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"...   of new OAC (NOAC) also appeared. In Russia, dabigatran, rivaroxaban and apixaban have been registered ..."
 
Vol 6, No 4 (2010) GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY Abstract  similar documents
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev
"... (Германия); Per Anton Sirnes (Норвегия); Michal Tendera (Польша); Panos Vardas (Греция); Petr Widimsky ..."
 
Vol 6, No 3 (2010) GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY Abstract  similar documents
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev
"... (Германия); Per Anton Sirnes (Норвегия); Michal Tendera (Польша); Panos Vardas (Греция); Petr Widimsky ..."
 
Vol 10, No 6 (2014) THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY Abstract  similar documents
A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev
"... problems. New oral anticoagulants (NOAC) are promising drugs for use in oncology practice; however ..."
 
Vol 9, No 3 (2013) ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING Abstract  similar documents
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova
"... 1000 patients. It would reduce the total costs per patient during 10 years. V/A therapy is able to save ..."
 
Vol 15, No 4 (2019) The Therapy with Oral Anticoagulants in Patients with Atrial Fibrillation in Outpatient and Hospital Settings (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
"... .7 years, 43.1% men. The incidence of OAC administration was evaluated in hospital and outpatient settings ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... oral anticoagulants (NOAC) instead of vitamin K antagonists (eg, warfarin), low doses of NOAC, studied ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... This article affects  the problems of using NOAC in the most defenseless groups  of patients ..."
 
Vol 10, No 2 (2014) PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM Abstract  PDF (Eng)  similar documents
A. M. Kalinina, A. V. Kontsevaya
"... -aged men during 15-year follow-up; to evaluate economic efficiency of primary medical prevention ..."
 
Vol 11, No 3 (2015) EVALUATION OF THE REGULARITY OF ANTIHYPERTENSIVE DRUGS USAGE AS A COMPONENT OF TREATMENT ADHERENCE IN OUTPATIENTS OF A SPECIALIZED CARDIOLOGY CENTER Abstract  PDF (Eng)  similar documents
A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S.B B. Fitilev
"... .8), those without coronary heart disease (OR=1.9), with hypertension duration less than 5 years (OR=1 ..."
 
Vol 15, No 2 (2019) Studies of Anticoagulant Therapy in Frail Elderly Patients: Problems of Terminology and Methodology Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov, G. Yu. Trufanova
"... oral anticoagulants (NOAC): 1) none of the randomized controlled trials (RCTs) with NOAC (except ..."
 
Vol 9, No 4 (2013) NORVASC® IN RUSSIA 20 YEARS LATER: CONTINUATION OF THE HISTORY Abstract  similar documents
A. V. Rudenko, B. A. Rudenko
"... поколений. Его высокая антигипертензивная активность не вызывает сомнения. Но при выборе амлодипина для ..."
 
Vol 3, No 2 (2007) CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP) Abstract  similar documents
V. A. Shulman, S. E. Golovenkin, V. V. Radionov, T. M. Parfenova, G. V. Matyushin
"... infarction (MI) as well as predisposing factors during 15-year follow-up. Material and methods. 1453 ..."
 
Vol 11, No 5 (2015) Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years Abstract  similar documents
A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk
"... a year. Aim. To study excess cardiovascular morbidity during winter in Ivanovo Region in 2009-2013 years ..."
 
Vol 13, No 3 (2017) ARTERIAL STIFFNESS AND CARDIOVASCULAR RISK FACTORS IN YOUNG MEN (41-44 YEARS) Abstract  PDF (Eng)  similar documents
O. Yu. Isaykina, V. B. Rozanov, E. Yu. Zvolinskaya, H. S. Pugoeva, A. A. Alexandrov
"... and subclinical atherosclerosis in young men. Material and methods. The study is part of a 32-year prospective ..."
 
Vol 15, No 6 (2019) Safety of Non-Vitamin K Oral Anticoagulants in Elderly Patients with Atrial Fibrillation Abstract  similar documents
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... Aim. To study the safety of non-vitamin K oral anticoagulants (NOAC) in patients with atrial ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... rates for St. Petersburg in 2014. The cost and life expectancy were discounted at 3.5% per year ..."
 
Vol 14, No 3 (2018) HEART RATE LEVELS IN THE POPULATIONS OF THE RUSSIAN FEDERATION AND THE UNITED STATES OF AMERICA DURING THE THIRTY-YEAR PERSPECTIVE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. G. Vilkov, A. V. Kapustina, A. D. Deev
"... number of cases was 48974. Results. In 80th years of XX century Russian men and women of all age groups ..."
 
Vol 15, No 3 (2019) The Prevalence of Smoking in 41-43-Year-Old Males and its Relation to Some Risk Factors Abstract  PDF (Eng)  similar documents
A. A. Alexandrov, M. V. Kotova, E. I. Ivanova, V. B. Rozanov
"... Aim. To evaluate the prevalence of smoking in 41-43-year-old men living in Moscow and its ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... . The costs and life expectancy of patients were discounted at 3.5% per year. Results. The best results ..."
 
Vol 11, No 2 (2015) THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY) Abstract  similar documents
G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun
"... syndrome components on the basis of a 5-year follow-up. Material and methods. An outpatient examination ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... Aim. To evaluate in a prospective 10-year follow-up study cardiovascular mortality rate ..."
 
Vol 2, No 1 (2006) PROPAFENONE FOR SINUS RHYTHM RECOVERY AND SUPPORT IN PATIENTS WITH PERSISTENT FORM OF AURICULAR FIBLILLATION. “PROMETHEUS” – OPENED MULTICENTER STUDY IN RUSSIAN FEDERATION Abstract  similar documents
I. G. Fomina, A. I. Tarzimanova, A. V. Vetluzsky, , , , , , , , , , , , , , , , ,
"... . 503 patients with the persistent form of AF, aged 31-68 years were included into multicenter study ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... Aim. To assess five-year trend in terms of specialists’ adherence to guidelines on secondary ..."
 
Vol 15, No 5 (2019) Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis Abstract  similar documents
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok
"... Aim. To compare the results of 3-year follow-up of patients with peripheral atherosclerosis (PA ..."
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
"... to recommended therapy on the risk of cardiovascular events during a year after hospital admission ..."
 
Vol 13, No 5 (2017) IRON DEFICIENCY AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
N. I. Stuklov
"... В статье рассматриваются проблемы дефицита железа и анемии при хронической сердечной ..."
 
Vol 14, No 6 (2018) Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) Abstract  PDF (Eng)  similar documents
L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk
"... coronary syndrome (ACS) in real clinical practice within a year after the index event. Material and methods ..."
 
Vol 3, No 5 (2007) RENAL HEMODYNAMICS AND GLOMERULAR FILTRATION RATE IN MEN AND WOMEN WITH ARTERIAL HYPERTENSION AT THE AGE OF 40-60 YEARS Abstract  similar documents
I. G. Fomina, A. E. Bragina, N. E. Gaydamakina, J. N. Salimzhanova
"... отрицательная связь средней силы между ОСКФ и индексом массы тела (ИМТ) (r=-0,41; p<0,005). Заключение. При ГБ ..."
 
Vol 7, No 2 (2011) LIPRIMAR®. FIFTEEN YEARS OF EVIDENCE Abstract  similar documents
A. V. Susekov, N. V. Khokhlova
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... included 184 healthy persons. Genotyping with single-nucleotide substitutions of the endothelial ..."
 
Vol 8, No 2 (2012) COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
O. P. Bobrova, M. M. Petrova
"... . Patients (n=40) 75–90 emyears/em with HT were included in the open randomized comparative study. Patients were ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"...   (CHF)  during  three emyear/em follow-up. Material and methods. A total of 211 patients with CHF experienced ..."
 
Vol 13, No 6 (2017) ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES Abstract  similar documents
Yu. V. Semenova, A. V. Zagrebelnyy, N. P. Kutishenko, M. L. Ginzburg, S. Yu. Martsevich
"... during the last emyears/em on the basis of the LIS-3 registry data. Material and methods. Data of acute ..."
 
Vol 13, No 1 (2017) SERGEY A. BOYTSOV IS 60 YEARS OLD Abstract  similar documents
статья Редкционная
 
Vol 6, No 5 (2010) 5 YEARS WITH RATIONAL PHARMACOTHERAPY IN CARDIOLOGY Abstract  similar documents
"... 5 emyears/em with Rational Pharmacotherapy in Cardiology. ..."
 
Vol 12, No 1 (2016) Leonid B. Lazebnik is 75 years Abstract  similar documents
Editorial article
 
Vol 9, No 6 (2013) FEATURES OF SEASONAL CARDIOVASCULAR MORTALITY IN WINTER IN RUSSIAN REGIONS WITH DIFFERENT CLIMATIC AND GEOGRAPHICAL CHARACTERISTICS Abstract  similar documents
S. A. Boytsov, M. M. Lukyanov, A. V. Kontsevaya, A. D. Deev, Yu. A. Balanova, A. V. Kapustina, V. G. Klyashtorny, M. B. Hudyakov
"... .9% emper/em emyear/em and emper/em January-March, December, respectively (p0.0001). Higher cardiovascular mortality ..."
 
Vol 16, No 2 (2020) LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period Abstract  similar documents
S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh
"... the cardiology department over a 4-emyear/em period in patients after acute coronary syndrome (ACS) with ST segment ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
"... events, summarized as events emper/em 100 patient-emyears/em, expected life emyears/em, total costs, and incremental ..."
 
Vol 16, No 3 (2020) The Main Cardiovascular Complications and Mortality Rates During the First One and a Half Years after Acute Myocardial Infarction: Data from the Prospective Outpatient Registry PROFILE-IM Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, E. A. Kasparova, A. V. Zagrebelnyy, Yu. V. Lukina, V. A. Evdakov
"... was 1.5 emyears/em. The primary combined endpoint (PCE) included death from any cause, cardiovascular events ..."
 
Vol 13, No 5 (2017) ANATOLY I. MARTYNOV IS 80 YEARS OLD! Abstract  similar documents
статья Редакционная
 
Vol 13, No 6 (2017) Pavel Ya. Dovgalevsky is 70 years old! Abstract  similar documents
article editotial
 
Vol 14, No 1 (2018) ACADEMICIAN YURY N. BELENKOV IS 70 YEARS OLD Abstract  similar documents
article editorial
 
Vol 14, No 5 (2018) Professor Ildus A. Latfullin is 80 years old Abstract  similar documents
article Editorial
 
Vol 5, No 3 (2009) ACADEMICIAN E.I. CHAZOV – 80 YEARS OLD Abstract  similar documents
"... Academician E.I. Chazov – 80 emyears/em old. ..."
 
Vol 5, No 5 (2009) ACADEMICIAN E.I. SOKOLOV – 80 YEARS OLD Abstract  similar documents
"... Academician E.I. Sokolov – 80 emyears/em old. ..."
 
Vol 12, No 6 (2016) VLADIMIR S. ZADIONCHENKO IS 75 YEARS OLD! Abstract  similar documents
. editorial
 
Vol 12, No 2 (2016) LIPID-LOWERING THERAPY IN OUTPATIENT PRACTICE (ACCORDING TO THE ARGO-2 STUDY) Abstract  similar documents
N. M. Akhmedzhanov, D. V. Nebieridze, A. S. Safaryan, V. A. Vygodin, A. Yu. Shuraev, A. N. Tkacheva, A. S. Lishuta
"... cardiovascular risk patients in real outpatient practice. Material and methods. Patients ≥30 emyears/em, visited ..."
 
Vol 7, No 5 (2011) ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva
"... and international normalized ratio (INR) control for patients with atrial fibrillation (AF) emper/em 1 emyear/em of treatment ..."
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... of major bleeding was 1.7 emper/em 100 patient-emyears/em, and gastrointestinal bleeding was 0.7 emper/em 100 patient ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... and life-emyears/em) were discounted at 3.5%. Cost-effectiveness threshold was set at 1.4 million rubles emper/em ..."
 
Vol 12, No 6 (2016) THE PROGNOSIS IN TRANSCATHETER AORTIC VALVE IMPLANTATION Abstract  similar documents
T. E. Imaev, A. E. Komlev, R. S. Akchurin
"... replacement, immediately after surgery, before the expiry of 30 days. Mean follow-up was 2.2 emyears/em (range 0 ..."
 
Vol 7, No 5 (2011) ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina
"... 516 772.42 RUR for every 1 000 patients. It would reduce the total costs emper/em patient during 10 emyears/em ..."
 
Vol 15, No 6 (2019) Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up) Abstract  similar documents
O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, I. V. Leontyeva, M. B. Kotova, E. I. Ivanova
"... aged 12-13 emyears/em with the development of structural and functional changes in the left ventricle ..."
 
Vol 5, No 3 (2009) REPERFUSION THERAPY IN ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION Abstract  similar documents
A. L. Alyavi, B. A. Alyavi
"... (first group). 25 patients of the second group had STL with Streptokinase, i/v, 1 500 000 units emper/em hour ..."
 
Vol 11, No 3 (2015) RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... in 3 emyears/em. Material and methods. Patients with dyslipidemia (113 patients in 2011 and 100 patients ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... of efficacy and safety data. Time horizon was set at 3 emyears/em. Quality Adjusted Life emYears/em (QALY) were used ..."
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... 49558.43 rubles for one patient emper/em emyear/em. The strategy of apixaban application costs higher by 0 ..."
 
Vol 7, No 1 (2011) THE CHOICE OF THE DRUG AMLODIPINE FOR THE HYPERTENSION TREATMENT FROM THE STANDPOINT OF ECONOMIC FEASIBILITY Abstract  similar documents
S. Yu. Martsevich, N. A. Dmitrieva, A. D. Deev, Yu. V. Lukina, L. A. Sokolova, V. V. Yakusevich
"... . In case of insufficient antihypertensive effect dose of amlodipine was increased to 10 mg emper/em day ..."
 
Vol 12, No 5 (2016) Statins in Secondary Prevention of Atrial Fibrillation Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, R. G. Gataulin
"... group II (n=32) did not take statins. The duration of follow-up was 4 emyears/em. The evolution of the AF ..."
 
Vol 7, No 1 (2011) RESULTS OF TENEKTEPLASE USE IN MASSIVE PULMONARY THROMBOEMBOLISM. CLINICAL CASE Abstract  similar documents
R. Rajan, R. Natarajan, G. Vijayaraghavan
"... in the literature. Clinical case of the tenekteplase use in 42 emyears/em old woman with acute massive PTE and its ..."
 
Vol 14, No 3 (2018) RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME Abstract  similar documents
V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev
"... ). Material and methods. 112 patients (mean age 61.4±7.2 emyears/em) with MS (average duration of MS 8.7±5.2 emyears/em ..."
 
Vol 12, No 4 (2016) Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation Abstract  similar documents
S. G. Kanorskii
"... major bleeding occurred in 128 patients (2.1 events emper/em 100 patient-emyears/em), 118 (1.9 events emper/em 100 ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... , performed from 2004 to 2009 emyears/em. Results. The total amount of patients was 17345. Majority of them ..."
 
Vol 9, No 6 (2013) ASSESSMENT OF SYSTEMIC INFLAMMATORY REACTION IN ACUTE MYOCARDIAL INFARCTION: STATUS UPDATE ON THE PROBLEM Abstract  similar documents
M. A Kachkovsky, E. Yu. Ragozinа
"... inflammation in the acute coronary syndrome over the last 10 emyears/em was carried out. The problems of application ..."
 
Vol 6, No 6 (2010) EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER) Abstract  similar documents
T. A. Istomina, E. V. Serdechnaya, L. A. Kulminskaya, B. A. Tatarskiy, E. V. Kazakevich, V. L. Lipskiy, S. I. Martyushov
"... ). emПри/em возникновении рецидива аритмии и его давности до 48 ч проводили кардиоверсию амиодароном или ..."
 
Vol 14, No 1 (2018) THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA Abstract  PDF (Eng)  similar documents
S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina
"... .05 in all groups except for men aged 25-34 emyears/em (distinctions are absent) and women aged 25-34 ..."
 
Vol 8, No 6 (2012) ASSESSMENT OF CORONARY ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH FIVE YEAR HISTORY OF MYOCARDIAL INFARCTION DEPENDING ON THE STATIN THERAPY COMPLIANCE Abstract  similar documents
A. I. Chesnikova, V. A. Safronenko, A. V. Hripun
"... Aim. To study the coronary atherosclerosis progression in patients with 5-emyear/em history ..."
 
Vol 5, No 6 (2009) PRESS RELEASE: SIGNIFICANT EXTEND OF POSSIBILITIES FOR REGIONAL CARDIOLOGISTS – THE MAIN TASK OF THE SECOND YEAR NATIONAL AWARD IN CARDIOLOGY “PURPLE HEART” Abstract  similar documents
"... of the second emyear/em National award in cardiology “Purple heart”. ..."
 
Vol 15, No 1 (2019) The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years Abstract  similar documents
S. A. Shalnova, O. M. Drapkina
"... in mortality from both causes in all age groups, with the exception of 75 emyears/em and older. For women in the age ..."
 
Vol 3, No 5 (2007) CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, J. B. Zverkov, V. V. Pisarev, I. E. Koltunov, V. G. Belolipetskaya, S. J. Martsevich
"... .o.) with AH duration 0,5-43 emyears/em (average - 17,9 emyears/em). Antihypertensive effect of Amlorus (Synthesis ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... and methods. A total of 291 female patients less than 60 emyears/em of age with a definite diagnosis of RA were ..."
 
Vol 12, No 6 (2016) EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev
"... diseases diseases (CSD) under 3-emyear/em follow-up in outpatient clinics. Methods. The efficiency of influenza ..."
 
Vol 14, No 1 (2018) THE INCIDENCE OF THE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING Abstract  similar documents
E. A. Bulgakova, F. B. Shukurov, B. A. Rudenko, T. V. Tvorogova, O. M. Drapkina
"... to 83 emyears/em (mean age of 60.6±3.9 emyears/em) there were 68 men (80.95%) and 16 women (19.05%). 39 (46 ..."
 
Vol 7, No 4 (2011) VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova
"... substitution with generic. Material and methods. Patients (n=36) with HT of 1-2 degree aged 41-82 emyears/em ..."
 
Vol 14, No 2 (2018) CHANGE IN THE FUNCTIONAL STATE OF ERYTHROCYTES AS A COMPONENT OF MICROCIRCULATORY DISORDERS IN METABOLIC SYNDROME Abstract  similar documents
V. I. Podzolkov, T. V. Koroleva, A. Е. Bragina, M. G. Kudryavtseva, N. A. Druzhinina, M. V. Pisarev
"... ) depending on glycemia levels. Material and methods. 112 patients (45 men and 67 women, age 61.4Ѓ}7.2 emyears/em ..."
 
Vol 11, No 5 (2015) Assessment of lipid profile when using lipid-lowering therapy (statins) in patients with coronary atherosclerosis Abstract  similar documents
N. E. Gavrilova, V. A. Metelskaya, E. B. Yarovaya, N. V. Gomyranova, S. A. Boytsov
"... of lipid-lowering therapy. Material and methods. A total of 502 patients aged 25-86 emyears/em (mean age 61.2±9 ..."
 
Vol 8, No 2 (2012) PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION Abstract  similar documents
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva
"... with essential HT (aged 18 to 70 emyears/em, 11 males and 27 females) associated with metabolic syndrome, and having ..."
 
Vol 15, No 4 (2019) Antimicrobial Treatment of Infective Endocarditis, Caused by Enterococcus Faecalis Abstract  PDF (Eng)  similar documents
E. V. Shikh, T. E. Morozova, V. N. Drozdov, N. B. Lazareva, D. A. Shatsky, T. B. Andrushchyshina, M. V. Lukina, O. A. Vartanova
"... The frequency of infective endocarditis (IE) has increased 3 times over the past 30 emyears/em ..."
 
Vol 13, No 1 (2017) DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT Abstract  similar documents
D. А. Napalkov, A. A. Sokolova, V. V. Fomin
"... . The analysis of various RCP data bases published over the past 2 emyears/em shows that, among all new oral ..."
 
Vol 13, No 6 (2017) CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE Abstract  similar documents
A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina
"... the replacement of clopidogrel with ticagrelor or an increase in the clopidogrel maintenance dose to 150 mg emper/em ..."
 
Vol 13, No 5 (2017) POLYMORPHISMS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AS PREDICTORS OF WOLFF-PARKINSON-WHITE SYNDROME Abstract  similar documents
G. V. Matyushin, S. Yu. Nikulina, A. A. Chernova, I. I. Lebedeva, A. A. Semenchukov
"... groups  and detected in 1-30 people emper/em 10000, it manifests mainly in young age (on average 20 emyears/em ..."
 
Vol 15, No 6 (2019) Association of Self-Perceived Health with Social and Psychological Environment, the Mode of Life and Cardiovascular Risk Markers in Middle-Aged Men – Residents of Moscow Abstract  PDF (Eng)  similar documents
M. B. Kotova, V. B. Rozanov, E. I. Ivanova
"... of 301 men aged 41-44 emyears/em were examined. The study included clinical examination and interrogation ..."
 
1 - 100 of 1032 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)